Login
| TI Ref No : | 526469394 |
|---|---|
| Description : | Active Ingredient: Fremanezumab; Atc Code: N02cd03; Dosage Form: All; Potency: All; Pack Size: All (excluding Clinical Packs) |
| Date : | 2025-12-20 |
| Deadline : | 2026-03-18 |
| Document Type : | Tenders |
| TI Ref No : | 526469394 |
|---|---|
| Description : | Active Ingredient: Fremanezumab; Atc Code: N02cd03; Dosage Form: All; Potency: All; Pack Size: All (excluding Clinical Packs) |
| Date : | 2025-12-20 |
| Deadline : | 2026-03-18 |
| Document Type : | Tenders |